appointments

News

Paulo Fontoura, currently chief medical officer of Xaira Therapeutics, will replace Houmab Ashrafian as Sanofi's R&D head on 1st September.

News

Amid the push to digitise the UK health service, a study has sounded a note of caution about entrusting important patient appointments to chatbots.

News

EVERSANA has named Jen Norton as president of its recently formed Market Access & Value division.

R&D

Boardrooms and advisory panels across biotech, pharma, digital health, and life sciences suppliers saw a wave of high‑profile additions in April.

Digital

Leadership changes across digital health, diagnostics, clinical trial technology, and life sciences suppliers continued in April.

R&D

April didn’t see too much activity at the big pharmas, but saw plenty of executive movement at small and midsized biotechs.